Year End Summary for CAM issues
AAPr Banner AAPR Logo
December 2013
Year End Summary - CAM issues
large_box_top.gif
It's been an interesting year for cancer complementary and alternative medicine (CAM) issues:
  • More and more studies demonstrate the value of complementary treatments - is this a tipping point?***
  • Many new books published by cancer survivors/thrivers describing their personal journeys.
  • Find updates on our Facebook page and on our website on all CAM issues
*** At two recent cancer conferences, several posters presented on dietary supplements, exercise (well-established now, relaxation, ditto, more info soon)

Link to Annie Appleseed Project
Our website is being updated continually but this year has been a challenge.  Work in progress!
large_box_bottom.gif
spacer.gif
How Evidence is Gathered (how research is done)

If you follow us on Twitter or read our posts on Facebook, you know that one of our more common rants is about HOW MUCH EVIDENCE is needed before a simple, natural technique is acceptable to mainstream oncology.

We also often point out that lots of research is done around breast cancer issues.  We know this causes pangs of envy among other cancer survivors, but there are several reasons for this.
  • There are many MORE breast cancer patients and survivors than with other cancers (oh wait did you mention prostate?)
  • Women mobilized more than 20 years ago as Advocates (the men fell behind on this and are still catching up).
  • Other cancer groups now have funding from the Dept of Defense which was a key factor in moving different sorts of research forward AND including patients 'at the table'.
But it is also important to note that in the natural world, treatments are not really cancer-specific.  So that what may work for one solid tumor, may indeed work with others. 

If/when mainstream pays attention to its own research indicating that our individual molecular profile may have genes turned on/off that differ in the same type of cancer, but are similar to those in folks with other types of cancer.  This may lead to completely different understanding.  And hopefully to true Personalized treatments.

But that will ONLY happen (in our opinion) when complementary therapies are INTEGRATED into conventional care.    If we seek the BEST for anyone, this has to happen.
 
New tests are being examined
A simple and inexpensive blood test is being developed that can be used to screen patients for premalignant colorectal cancer (CRC) lesions which, once perfected, will be a real “game changer,” predict researchers at ESMO 15th World Congress on Gastrointestinal Cancer. - See more at: http://www.onclive.com/conference-coverage/world-GI/Simple-Inexpensive-Blood-Test-Poised-to-Be-a-Real-Game-Changer-in-CRC-Screening?utm_source=Informz&utm_medium=OncLive&utm_campaign=Stivarga#sthash.wR0SZ02h.dpuf
bloodtesting
A simple and inexpensive blood test is being developed that can be used to screen patients for premalignant colorectal cancer (CRC) lesions which, once perfected, will be a real “game changer,” predict researchers at ESMO 15th World Congress on Gastrointestinal Cancer. - See more at: http://www.onclive.com/conference-coverage/world-GI/Simple-Inexpensive-Blood-Test-Poised-to-Be-a-Real-Game-Changer-in-CRC-Screening?utm_source=Informz&utm_medium=OncLive&utm_campaign=Stivarga#sthash.wR0SZ02h.dpuf
A simple and inexpensive blood test is being developed that can be used to screen patients for premalignant colorectal cancer (CRC) lesions which, once perfected, will be a real “game changer,” predict researchers at ESMO 15th World Congress on Gastrointestinal Cancer. - See more at: http://www.onclive.com/conference-coverage/world-GI/Simple-Inexpensive-Blood-Test-Poised-to-Be-a-Real-Game-Changer-in-CRC-Screening?utm_source=Informz&utm_medium=OncLive&utm_campaign=Stivarga#sthash.wR0SZ02h.dpuf
A simple and inexpensive blood test is being developed that can be used to screen patients for premalignant colorectal cancer (CRC) lesions which, once perfected, will be a real “game changer,” predict researchers at ESMO 15th World Congress on Gastrointestinal Cancer. - See more at: http://www.onclive.com/conference-coverage/world-GI/Simple-Inexpensive-Blood-Test-Poised-to-Be-a-Real-Game-Changer-in-CRC-Screening?utm_source=Informz&utm_medium=OncLive&utm_campaign=Stivarga#sthash.wR0SZ02h.dpuf
 
A simple and inexpensive blood test is being developed that can be used to screen patients for premalignant colorectal cancer (CRC) lesions which, once perfected, will be a real “game changer,” predict researchers at ESMO 15th World Congress on Gastrointestinal Cancer. - See more at: http://www.onclive.com/conference-coverage/world-GI/Simple-Inexpensive-Blood-Test-Poised-to-Be-a-Real-Game-Changer-in-CRC-Screening?utm_source=Informz&utm_medium=OncLive&utm_campaign=Stivarga#sthash.wR0SZ02h.dpuf

A simple and inexpensive blood test is being developed that can be used to screen patients for premalignant colorectal cancer (CRC) lesions which, once perfected, will be a real “game changer,” predict researchers at ESMO 15th World Congress on Gastrointestinal Cancer.
What we want is to find a test that will be good enough that a person can be reassured that they do not need a colonoscopy for maybe a year, and that will change everything.” - See more at: http://www.onclive.com/conference-coverage/world-GI/Simple-Inexpensive-Blood-Test-Poised-to-Be-a-Real-Game-Changer-in-CRC-Screening?utm_source=Informz&utm_medium=OncLive&utm_campaign=Stivarga#sthash.wR0SZ02h.dpuf


"What we want is to find a test that will be good enough that a person can be reassured that they do not need a colonoscopy for maybe a year, and that will change everything.”, Dr. C. Richard Boland, MD.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
There were reports in the news of high school students science projects that offered advancements for cancer testing.  HOW LONG will it take to bring to market?  Annie Appleseed Project, sadly cynical after almost 20 years of Advocacy, believes there is very little impetus to 'prevent' or at least 'reduce risk' of cancer.  Even earlier testing is not getting the funding it needs.
Some years ago a few companies began looking into testing to see if tumors responded to particular types of chemotherapy.  They were almost universally reviled. 
Even more recently some companies began finding ways to test who really needed chemo treatment and who would not benefit.  GREAT idea. And each year there are new tests in other cancers. 
Would you SUPPORT our efforts to gather information so YOU can stay informed and educated on the issues we focus on?
                                                            AAPR Logo 2
DONATE   any amount
 We promise that 100% will go to our programs.
Frankincense - tis the season

frankincense "Researchers at the University of Leicester have discovered the compound AKBA, which is found in the plant resin frankincense, can kill cancer cells in late-stage ovarian cancer."


Ovarian/Frankincense study

However this article touches upon ANOTHER of Annie Appleseed Project RANTS.  It is NOT any single 'compound' within any natural substance but the ENTIRE herb that is really active.  When these individual elements are isolated, they are almost always TOXIC.  What's the point of trying to isolate?  To make a patentable drug.  Our cancer system is run by  BIG PHARMA.  If they cannot make money, a substance does NOT get explored.  How can this be the right direction?  Clearly IT IS NOT!
Annie Appleseed Project will host its 8th Evidence-based Complementary & Alternative Cancer Therapies conference on March 6-8, 2014 (starting Thursday at 2PM and ending Saturday around 5:15).

Link to conference page

Here's an excerpt from Dr. D. Maharaj's abstract:

"Autologous stem cells can be safely transplanted without being rejected by the body’s immune system  and they have unique characteristics compared to other sources of stem cells which makes them an increasing focus of research for clinical applications in regenerative medicine.

Autologous stem cell therapy is an established  treatment for immune dysfunction of  blood cancers . The  lifetime likelihood of an individual in the U.S. needing a  hemopoietic stem cell transplant, using either one’s own stem cells or those from a donor is 1 in 200  which is much higher than previously reported estimates( Biology of Blood and Marrow Transplantation, March 2008 ). In the future it is believed that the need for autologous stem cell therapy will increase as it may offer remedies for strokes and neurodegenerative conditions such as Parkinson’s and Alzheimer’s diseases and chronic diseases such as heart disease as well as diabetes."

WANT to hear more?  Register and attend.  We WILL have DVDs and MP3s available after the meeting if you really cannot be part of it. 
If you run a cancer advocacy, work for one, volunteer or are a CAM professional, this is the meeting to be part of. 

Cancer Strategies - Survivor/Activist Speaks Out

Our Guest - Ann Fonfa was diagnosed with breast cancer in 1993.  After extensive research in the field of alternative cancer therapies, Ann created the Annie Appleseed Project.  This show is perfect for every type of cancer patients and reveals what the conventional cancer industry will never tell you about how to successfully overcome a cancer diagnosis - without toxic drugs or risky surgical procedures.  If you're dealing with cancer - do not miss this educational program.
From Natural News Radio Hour (appearing Sunday, December 29 - on a continuous loop - tune in anytime to listen to this pre-recorded interview)
Tel: (561) 749-0084

Fax: (561)499-6424
Email: info@annieappleseedproject.org




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

The Annie Appleseed Project
7319 Serrano Terrace
Delray Beach, Florida 33446-2215
US

Read the VerticalResponse marketing policy.

Non-Profits Email Free with VerticalResponse!